# Anne Keogh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anne-keogh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,256 |
| Field | Transplantation: Methods and Outcomes |
| h-index | 70 |
| i10-index | 201 |
| Last Known Institution | The University of Sydney |
| OpenAlex ID | https://openalex.org/A5073502710 |
| ORCID iD | 0000-0002-8788-603X |
| Works | 438 |

## Researcher papers

Showing 12 of 16.

- [Bosentan Therapy for Pulmonary Arterial Hypertension](https://scholariq.org/papers/bosentan-therapy-for-pulmonary-arterial-hypertension/)
- [The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients](https://scholariq.org/papers/the-international-society-of-heart-and-lung-transplantation-guidelines-for-the/)
- [Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial](https://scholariq.org/papers/continuous-subcutaneous-infusion-of-treprostinil-a-prostacyclin-analogue-in/)
- [Riociguat for the Treatment of Pulmonary Arterial Hypertension](https://scholariq.org/papers/riociguat-for-the-treatment-of-pulmonary-arterial-hypertension/)
- [Updated Treatment Algorithm of Pulmonary Arterial Hypertension](https://scholariq.org/papers/updated-treatment-algorithm-of-pulmonary-arterial-hypertension/)
- [A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1](https://scholariq.org/papers/a-randomized-active-controlled-trial-of-mycophenolate-mofetil-in-heart/)
- [Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease](https://scholariq.org/papers/integrated-allelic-transcriptional-and-phenomic-dissection-of-the-cardiac/)
- [Ambrisentan Therapy for Pulmonary Arterial Hypertension](https://scholariq.org/papers/ambrisentan-therapy-for-pulmonary-arterial-hypertension/)
- [Sirolimus in De Novo Heart Transplant Recipients Reduces Acute Rejection and Prevents Coronary Artery Disease at 2 Years](https://scholariq.org/papers/sirolimus-in-de-novo-heart-transplant-recipients-reduces-acute-rejection-and/)
- [Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series](https://scholariq.org/papers/adult-heart-transplantation-with-distant-procurement-and-ex-vivo-preservation-of/)
- [Mutations in Cardiac T-Box Factor Gene TBX20 are associated with Diverse Cardiac Pathologies, Including Defects of Septation and Valvulogenesis and Cardiomyopathy](https://scholariq.org/papers/mutations-in-cardiac-t-box-factor-gene-tbx20-are-associated-with-diverse-cardiac/)
- [Outcomes of Donation After Circulatory Death Heart Transplantation in Australia](https://scholariq.org/papers/outcomes-of-donation-after-circulatory-death-heart-transplantation-in-australia/)

## Researcher topics

- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Cardiac Structural Anomalies and Repair](https://scholariq.org/topics/cardiac-structural-anomalies-and-repair/)

## Researcher university

- [The University of Sydney](https://scholariq.org/institutions/the-university-of-sydney/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.